Julian S Gangolli - Net Worth and Insider Trading

Over the past 18 months, Julian S Gangolli made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian S Gangolli made 1 insider transaction in Krystal Biotech Inc (KRYS) with a net sale of 20,000. Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 300,000 shares made by Krish S Krishnan , a net sale of 300,000 shares made by Suma Krishnan , and a net sale of 23,087 shares made by Kathryn Romano .

In summary, during the past 3 months, insiders sold 100,000 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 643,087 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 643,087 shares.

Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian S Gangolli made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 22,558 shares made by Mark J Foley , a net sale of 42,978 shares made by Dwight Moxie , and a net sale of 11,062 shares made by Tobin Schilke .

In summary, during the past 3 months, insiders sold 3,908 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 3,908 shares. During the past 18 months, 122,109 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 92,109 shares.

Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.